About 28 Trademarks found that are owned by Xencor Inc.

PHARMACEUTICAL PREPARATIONS FOR [ HORMONE REPLACEMENT THERAPIES, CANCER GENE THERAPY, DIABETES THERAPY, T CELL THERAPY, BLOOD GROWTH FACTORS, NEURAL GROWTH FACTOR THERAPY, ANTI-COAGULANT THERAPY, BIOLOGICAL RESPONSE MODIFIER THERAPY, ] ANTI-CANCER ANTIBODY THERAPY [, ANTI-VIRAL THERAPY, ANTI-MICROBIAL THERAPY, DRUG SCREENING REAGENTS, namely, CYTOKINE RECEPTOR ASSAY REAGENTS, HIGH THROUGHPUT ASSAYS; BIOTECHNOLOGICAL PREPARATIONS FOR MEDICAL OR VETERINARY PURPOSES, BEING PULP AND PAPER PROCESSING ENZYMES, namely, XYLANESE FOR BLEACH BOOSTING, PITCH REDUCTION LIPASES, CELLULASES FOR BLEACH BOOSTING; DETERGENT ENZYMES, namely, DETERGENT PROTEASES, DETERGENT CELLULASES, DETERGENT LIPASES; WASTE REMEDIATION ENZYMES, namely, DEHALOGENASE ENZYMES; BIOMASS PROCESSING ENZYMES, namely, CELLULASES, AMYLASES, GLUCOAMYLASES ]

"PROTEINS"

pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders

Medical and scientific research and development services for third parties in the field of pharmaceuticals; scientific consulting services for third parties in the field of pharmaceuticals

computer programming services for automated molecular design and biotechnology and pharmaceutical research and development; consulting services in the pharmaceutical and biotechnology fields

Pharmaceutical and biological product development consultation relating to monoclonal antibodies; and pharmaceutical and biological product development for others relating to monoclonal antibodies

Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for therapeutic use for the treatment of cancer and proliferative cell diseases

"PROTEIN" and "AUTOMATION"

Pharmaceutical preparations, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders

Biochemicals, namely, antibodies and fragments thereof for research and development; biochemicals, namely, antibodies and fragments thereof and polypeptides for general manufacturing; biochemicals, namely, antibodies and fragments thereof and polypeptides for use in the manufacture of pharmaceuticals for the treatment of oncological and autoimmune diseases and disorders

pharmaceutical preparations for hormone replacement therapies, namely cancer gene therapy, diabetes therapy, T-Cell therapy, blood growth factors, neural growth factor therapy, anti-coagulant therapy, biological response modifier therapy, anti-cancer antibody therapy, anti-viral therapy, anti-microbial therapy; drug screening reagents, namely cytokine receptor assay reagents; and high throughput assays

biotechnological products, being pulp and paper processing enzymes, namely xylanase for bleach boosting, pitch reduction lipases, cellulases for bleach boosting; detergent enzymes, namely, detergent proteases, detergent cellulases, detergent lipases; waste remediation enzymes, namely, dehalogenase enzymes; biomass processing enzymes, namely, cellulases, amylases, and glucoamylases

medical and scientific research and development services for third parties; medical and scientific consulting services for third parties